アレルギー性鼻炎に対する皮下アレルゲン特異免疫療法: 鼻粘膜と血液における異なったIgA反応,リンパ節と血液におけるB細胞のクラス交換の検証
Maryam Jafari1, Marianne Petro1, Eirini Paziou1,2
1Division of Ear, Nose, and Throat Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Clinical and translational allergy
|September 2, 2025
まとめ
アレルギー性鼻炎に対する皮膚下免疫療法 (SCIT) は症状を軽減し,免疫グロブリン濃度を変化させます. SCITは全身IgAとIgG4を増加させ,局所IgAを減少させ,免疫効果の差異を示唆する.
科学分野:
- 免疫学
- アレルギー学
- 臨床医学
背景:
- 皮下免疫療法 (SCIT) は,アレルギー性鼻炎 (AR) の長年の治療法である.
- SCITはARの症状を効果的に軽減し,免疫反応を調節する.
- SCITの有効性,特に局所免疫反応のメカニズムについては,さらなる解明が必要である.
研究 の 目的:
- 血液と鼻の粘膜における免疫グロブリン産生に対するSCITの影響を調査する.
- SCIT後の血液とリンパ節のB細胞のクラス交換を評価する.
- AR患者の臨床結果と免疫学的変化を相関させる.
主な方法:
- SCITの投与前と後の23人のAR患者から採取した血液,鼻洗い (NAL),リンパ節細針吸い (FNA).
- アレルゲン固有のIgE,IgA,IgG,およびIgG4をELISAを用いて測定した.
- フローサイトメトリーでB細胞のクラス交換を評価し,症状と薬剤のスコアを使用して臨床反応を評価した.
主要な成果:
- SCITの投与量増加は,ARの症状,薬の使用,およびベースフィルの感受性を減少させた.
- アレルゲン固有のIgA,IgG,IgG4の血濃度がSCIT後に増加した.
- NALではアレルゲン固有のIgEとIgAが減少し,血液とリンパ節では記憶B細胞が増加した.
結論:
- SCITは局所的および全身的免疫に差異的な効果を誘導する.
- 早期の免疫学的変化には,全身IgA/ IgG4の増加と粘膜IgAの減少が含まれます.
- SCITの有効性を評価するには,粘膜と全身の反応の両方を評価することが重要です.
関連する概念動画
02:06Allergic Reactions
28.5K
Overview
28.5K
01:24B Cell Activation and Differentiation
5.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
5.5K
01:10Antibody Structure
61.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.2K
01:27Allergic Drug Reactions
972
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
972
01:23Cells of the Adaptive Immune Response
4.0K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.0K